Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of pharmacokinetics in case reports of haemodialysis patients.
|Full bibliographic reference||Gotta V, Dao K, Rodieux F, Buclin T, Livio F, Pfister M. Guidance to develop individual dose recommendations for patients on chronic hemodialysis. Expert Rev Clin Pharmacol. 2017;10(7):737-752.|
|Study design||Observational studies|
|Clinical area||Haematology, Pharmaceutical medicine, Renal medicine|
|Applies to the whole report or to individual sections of the report?||Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.)|
|Record last updated on||July 26, 2017|
|Diagnostic / prognostic studies||STARD||TRIPOD|
|Quality improvement studies||SQUIRE|
|Animal pre-clinical studies||ARRIVE|
|Clinical practice guidelines||AGREE||RIGHT|
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.
Our full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.